Literature DB >> 7143223

Effect of dose size on the pharmacokinetics of oral hydrocortisone suspension.

R D Toothaker, W A Craig, P G Welling.   

Abstract

The pharmacokinetics of hydrocortisone were examined following single doses of 5-, 10-, 20-, and 40-mg hydrocortisone suspensions to healthy male volunteers. Endogenous hydrocortisone was suppressed by giving 2 mg of dexamethasone the night before hydrocortisone administration. Plasma samples obtained serially for 12 hr after hydrocortisone administration were assayed by reversed-phase high-pressure liquid chromatography using a fixed-wavelength (254 nm) UV absorbance detector. Drug absorption was rapid, with mean maximum plasma hydrocortisone concentrations occurring within 60 min of dosing. Subsequent drug elimination was monophasic with mean elimination half-lives increasing from 1.2 hr for the 5-mg dose to 1.7 hr for the 40-mg dose. Increase in AUC and Cmax with increasing dose were linear but not directly proportional to dose size. This was attributed to dose-dependent absorption or to loss of drug the first-pass through the liver.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7143223     DOI: 10.1002/jps.2600711029

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  Population Pharmacokinetic-Pharmacodynamic Model of Oral Fludrocortisone and Intravenous Hydrocortisone in Healthy Volunteers.

Authors:  Noureddine Hamitouche; Emmanuelle Comets; Mégane Ribot; Jean-Claude Alvarez; Eric Bellissant; Bruno Laviolle
Journal:  AAPS J       Date:  2017-01-12       Impact factor: 4.009

2.  Improving glucocorticoid replacement in patients with adrenal insufficiency.

Authors:  Gudmundur Johannsson
Journal:  Endocrine       Date:  2016-04-04       Impact factor: 3.633

Review 3.  First-pass elimination. Basic concepts and clinical consequences.

Authors:  S M Pond; T N Tozer
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

4.  The Challenges of Cortisol Replacement Therapy in Childhood: Observations from a Case Series of Children Treated with Modified-Release Hydrocortisone.

Authors:  Julie Park; Urmi Das; Mohammed Didi; Renuka Ramakrishnan; Matthew Peak; Paul Newland; Joanne Blair
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

5.  Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults.

Authors:  Johanna Melin; Zinnia P Parra-Guillen; Niklas Hartung; Wilhelm Huisinga; Richard J Ross; Martin J Whitaker; Charlotte Kloft
Journal:  Clin Pharmacokinet       Date:  2018-04       Impact factor: 6.447

6.  Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey.

Authors:  M Forss; G Batcheller; S Skrtic; G Johannsson
Journal:  BMC Endocr Disord       Date:  2012-06-13       Impact factor: 2.763

7.  Novel HPLC Analysis of Hydrocortisone in Conventional and Controlled-Release Pharmaceutical Preparations.

Authors:  Ofosua Adi-Dako; Samuel Oppong Bekoe; Kwabena Ofori-Kwakye; Enoch Appiah; Paul Peprah
Journal:  J Pharm (Cairo)       Date:  2017-06-04

8.  Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency.

Authors:  A G Nilsson; C Marelli; D Fitts; R Bergthorsdottir; P Burman; P Dahlqvist; B Ekman; B Edén Engström; T Olsson; O Ragnarsson; M Ryberg; J Wahlberg; H Lennernäs; S Skrtic; G Johannsson
Journal:  Eur J Endocrinol       Date:  2014-06-18       Impact factor: 6.664

9.  Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.

Authors:  Gudmundur Johannsson; Hans Lennernäs; Claudio Marelli; Kevin Rockich; Stanko Skrtic
Journal:  Eur J Endocrinol       Date:  2016-04-29       Impact factor: 6.664

10.  A comparison of single-dose and multiple divided daily-dose oral steroids for sudden sensorineural hearing loss.

Authors:  Gun Hee Yu; Yong-Jun Choi; Hahn Jin Jung; Yun-Sung Lim; Seok-Won Park; Chang Gun Cho; Joo Hyun Park
Journal:  Braz J Otorhinolaryngol       Date:  2018-07-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.